A phase III trial of medications for castration resistance in metastatic prostate cancer
Cancer - Prostate,
Leslie Howard, MD
D’Amour Center for Cancer Care
3350 Main Street
Baystate Franklin Medical Center
164 High Street
The purpose of this study is to compare the effects, good and/or bad, of abiraterone, prednisone, and enzalutamide with enzalutamide alone on you and your prostate cancer to find out which is better.
Participants must have progressive castration-resistant metastatic prostate cancer, and rising PSA levels.